Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any self-limited epilepsy with centrotemporal spikes in which the cause of the disease is a variation in GRIN2A gene.
No clinical trials have been registered for GRIN2A-related self-limited epilepsy with centrotemporal spikes.
4 publications have been identified in PubMed for GRIN2A-related self-limited epilepsy with centrotemporal spikes. Kisho has analyzed 3 by research type. Research spans Other (33%), Basic Science / Preclinical (33%), and Epidemiology / Natural History (33%).
He Z (2025). [PMID: 40099767](https://pubmed.ncbi.nlm.nih.gov/40099767/). *CNS neuroscience & therapeutics*. [Epidemiology / Natural History]
Van Bogaert P (2025). [PMID: 39363819](https://pubmed.ncbi.nlm.nih.gov/39363819/). *Developmental medicine and child neurology*. [Other]
Zhang L (2024). [PMID: 39474911](https://pubmed.ncbi.nlm.nih.gov/39474911/). *Epilepsia open*. [Basic Science / Preclinical]
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 3:41 AM UTC
Common questions about GRIN2A-related self-limited epilepsy with centrotemporal spikes